Bellevue Group
Latest statistics and disclosures from Bellevue Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IONS, ARGX, NBIX, VRTX, ISRG, and represent 23.10% of Bellevue Group's stock portfolio.
- Added to shares of these 10 stocks: DXCM (+$43M), COO (+$40M), SAGE (+$18M), SIBN (+$17M), STE (+$17M), BEAM (+$17M), CLDX (+$16M), ANNX (+$16M), ESPR (+$15M), GPCR (+$15M).
- Started 23 new stock positions in IDYA, MDGL, TEVA, ADMA, OABI, RGNX, ASTH, GKOS, AAPL, ANNX. MLYS, MLTX, BIDU, FDMT, STE, BMY, SMPL, COO, BAX, BPMC, WST, GRMN, NEO.
- Reduced shares in these 10 stocks: AXNX (-$114M), ISRG (-$60M), NBIX (-$52M), Cooper Companies (-$33M), EVH (-$29M), VRTX (-$28M), ARGX (-$23M), MRNA (-$21M), APLS (-$20M), CRSP (-$19M).
- Sold out of its positions in AXNX, Cooper Companies, DVA, INBX, MCHI, Karuna Therapeutics Ord, KOS, LTH, LULU, NKE. XOP, SUPN, GDXJ, WW, ZLAB.
- Bellevue Group was a net seller of stock by $-233M.
- Bellevue Group has $6.6B in assets under management (AUM), dropping by 0.30%.
- Central Index Key (CIK): 0001674546
Tip: Access up to 7 years of quarterly data
Positions held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Bellevue Group
Bellevue Group holds 169 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals (IONS) | 5.5 | $360M | -4% | 8.3M | 43.35 |
|
| Argenx Se Sponsored Adr (ARGX) | 4.9 | $319M | -6% | 811k | 393.72 |
|
| Neurocrine Biosciences (NBIX) | 4.3 | $284M | -15% | 2.1M | 137.92 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.3 | $280M | -9% | 669k | 418.01 |
|
| Intuitive Surgical Com New (ISRG) | 4.2 | $272M | -18% | 682k | 399.09 |
|
| Boston Scientific Corporation (BSX) | 3.3 | $216M | 3.1M | 68.49 |
|
|
| Intra Cellular Therapies (ITCI) | 3.0 | $195M | -8% | 2.8M | 69.20 |
|
| Moderna (MRNA) | 2.8 | $182M | -10% | 1.7M | 106.56 |
|
| Dex (DXCM) | 2.6 | $169M | +33% | 1.2M | 138.70 |
|
| Revolution Medicines (RVMD) | 2.5 | $164M | 5.1M | 32.23 |
|
|
| Abbott Laboratories (ABT) | 2.5 | $163M | -6% | 1.4M | 113.66 |
|
| Stryker Corporation (SYK) | 2.5 | $161M | -3% | 449k | 357.87 |
|
| Macrogenics (MGNX) | 2.2 | $147M | 10M | 14.72 |
|
|
| Alnylam Pharmaceuticals (ALNY) | 2.1 | $137M | +3% | 918k | 149.45 |
|
| Incyte Corporation (INCY) | 1.9 | $123M | 2.2M | 56.97 |
|
|
| Celldex Therapeutics Com New (CLDX) | 1.8 | $117M | +15% | 2.8M | 41.97 |
|
| Agios Pharmaceuticals (AGIO) | 1.8 | $117M | 4.0M | 29.24 |
|
|
| Edwards Lifesciences (EW) | 1.6 | $105M | +8% | 1.1M | 95.56 |
|
| Becton, Dickinson and (BDX) | 1.6 | $103M | +7% | 416k | 247.45 |
|
| Arvinas Ord (ARVN) | 1.5 | $99M | -4% | 2.4M | 41.28 |
|
| Medtronic SHS (MDT) | 1.3 | $88M | +3% | 1.0M | 87.15 |
|
| Sage Therapeutics (SAGE) | 1.3 | $84M | +27% | 4.5M | 18.74 |
|
| EXACT Sciences Corporation (EXAS) | 1.2 | $79M | +8% | 1.1M | 69.06 |
|
| UnitedHealth (UNH) | 1.1 | $74M | +7% | 149k | 494.70 |
|
| Tandem Diabetes Care Com New (TNDM) | 1.1 | $72M | 2.0M | 35.41 |
|
|
| Essa Pharma Com New (EPIX) | 1.0 | $67M | 7.9M | 8.49 |
|
|
| Immunocore Hldgs Ads (IMCR) | 1.0 | $63M | 972k | 65.00 |
|
|
| Biohaven (BHVN) | 1.0 | $63M | +6% | 1.2M | 54.69 |
|
| Option Care Health Com New (OPCH) | 1.0 | $63M | -3% | 1.9M | 33.54 |
|
| Charles River Laboratories (CRL) | 0.9 | $62M | +5% | 230k | 270.95 |
|
| Insmed Com Par $.01 (INSM) | 0.9 | $58M | -6% | 2.1M | 27.13 |
|
| Axsome Therapeutics (AXSM) | 0.8 | $55M | +7% | 686k | 79.80 |
|
| Bio Rad Labs Cl A (BIO) | 0.8 | $54M | +10% | 157k | 345.87 |
|
| Hca Holdings (HCA) | 0.8 | $53M | +4% | 160k | 333.53 |
|
| Anthem (ELV) | 0.8 | $51M | -8% | 99k | 518.54 |
|
| Align Technology (ALGN) | 0.8 | $51M | -2% | 155k | 327.92 |
|
| IDEXX Laboratories (IDXX) | 0.8 | $50M | 93k | 539.93 |
|
|
| Insulet Corporation (PODD) | 0.8 | $50M | 294k | 171.40 |
|
|
| Accolade (ACCD) | 0.8 | $50M | +6% | 4.8M | 10.48 |
|
| Relay Therapeutics (RLAY) | 0.8 | $49M | 5.9M | 8.30 |
|
|
| Evolent Health Cl A (EVH) | 0.7 | $49M | -37% | 1.5M | 32.79 |
|
| Humana (HUM) | 0.7 | $47M | +34% | 136k | 346.72 |
|
| Inspire Med Sys (INSP) | 0.7 | $47M | 218k | 214.79 |
|
|
| Ge Healthcare Technologies I Common Stock (GEHC) | 0.7 | $47M | -4% | 512k | 90.91 |
|
| Exelixis (EXEL) | 0.7 | $45M | -9% | 1.9M | 23.73 |
|
| Eli Lilly & Co. (LLY) | 0.7 | $45M | +3% | 58k | 777.96 |
|
| Procept Biorobotics Corp (PRCT) | 0.7 | $44M | 890k | 49.42 |
|
|
| Black Diamond Therapeutics (BDTX) | 0.7 | $43M | 8.5M | 5.07 |
|
|
| Crispr Therapeutics Namen Akt (CRSP) | 0.6 | $42M | -31% | 620k | 68.16 |
|
| Caredx (CDNA) | 0.6 | $42M | 3.9M | 10.59 |
|
|
| Molina Healthcare (MOH) | 0.6 | $41M | +9% | 100k | 410.83 |
|
| Merck & Co (MRK) | 0.6 | $41M | +7% | 311k | 131.95 |
|
| Penumbra (PEN) | 0.6 | $40M | -10% | 181k | 223.18 |
|
| Cooper Cos (COO) | 0.6 | $40M | NEW | 397k | 101.46 |
|
| Beam Therapeutics (BEAM) | 0.6 | $39M | +71% | 1.2M | 33.04 |
|
| Veeva Sys Cl A Com (VEEV) | 0.6 | $39M | -13% | 168k | 231.69 |
|
| Scholar Rock Hldg Corp (SRRK) | 0.6 | $39M | 2.2M | 17.76 |
|
|
| Zimmer Holdings (ZBH) | 0.6 | $37M | 282k | 131.98 |
|
|
| Fate Therapeutics (FATE) | 0.5 | $36M | 4.8M | 7.34 |
|
|
| Shockwave Med (SWAV) | 0.5 | $34M | -15% | 106k | 325.63 |
|
| Sarepta Therapeutics (SRPT) | 0.5 | $33M | +5% | 252k | 129.46 |
|
| AmerisourceBergen (COR) | 0.5 | $32M | +4% | 132k | 242.99 |
|
| Globus Med Cl A (GMED) | 0.5 | $31M | -4% | 580k | 53.64 |
|
| Cigna Corp (CI) | 0.4 | $29M | -9% | 80k | 363.19 |
|
| Centene Corporation (CNC) | 0.4 | $29M | -17% | 363k | 78.48 |
|
| BioMarin Pharmaceutical (BMRN) | 0.4 | $28M | 322k | 87.34 |
|
|
| Apellis Pharmaceuticals (APLS) | 0.4 | $28M | -42% | 474k | 58.78 |
|
| Silk Road Medical Inc Common (SILK) | 0.4 | $28M | +5% | 1.5M | 18.32 |
|
| Castle Biosciences (CSTL) | 0.4 | $27M | 1.2M | 22.15 |
|
|
| Transmedics Group (TMDX) | 0.4 | $27M | -29% | 364k | 73.94 |
|
| Esperion Therapeutics (ESPR) | 0.4 | $27M | +136% | 9.9M | 2.68 |
|
| Wave Life Sciences SHS (WVE) | 0.4 | $25M | -8% | 4.1M | 6.17 |
|
| Natera (NTRA) | 0.4 | $25M | +5% | 270k | 91.46 |
|
| Thermo Fisher Scientific (TMO) | 0.4 | $23M | +13% | 40k | 581.21 |
|
| Hologic (HOLX) | 0.3 | $23M | 290k | 77.96 |
|
|
| Danaher Corporation (DHR) | 0.3 | $22M | +2% | 86k | 249.72 |
|
| Privia Health Group (PRVA) | 0.3 | $21M | 1.1M | 19.59 |
|
|
| Hutchmed China Sponsored Ads (HCM) | 0.3 | $19M | +2% | 1.2M | 16.80 |
|
| Si-bone (SIBN) | 0.3 | $19M | +810% | 1.1M | 16.37 |
|
| Verona Pharma Sponsored Ads (VRNA) | 0.3 | $18M | +35% | 1.1M | 16.09 |
|
| Pacific Biosciences of California (PACB) | 0.3 | $17M | -37% | 4.6M | 3.75 |
|
| Steris Shs Usd (STE) | 0.3 | $17M | NEW | 73k | 224.82 |
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.3 | $16M | +45% | 293k | 56.09 |
|
| Generation Bio (GBIO) | 0.2 | $16M | +6% | 3.9M | 4.07 |
|
| Annexon (ANNX) | 0.2 | $16M | NEW | 2.2M | 7.17 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.2 | $16M | +2858% | 364k | 42.86 |
|
| Neogenomics Com New (NEO) | 0.2 | $15M | NEW | 946k | 15.72 |
|
| AtriCure (ATRC) | 0.2 | $14M | -45% | 447k | 30.42 |
|
| 10x Genomics Cl A Com (TXG) | 0.2 | $12M | +5% | 308k | 37.53 |
|
| Phreesia (PHR) | 0.2 | $11M | +5% | 443k | 23.93 |
|
| Omnicell (OMCL) | 0.1 | $6.9M | +5% | 235k | 29.23 |
|
| Regeneron Pharmaceuticals (REGN) | 0.1 | $6.8M | -33% | 7.1k | 962.49 |
|
| Amgen (AMGN) | 0.1 | $6.3M | -35% | 22k | 284.32 |
|
| ResMed (RMD) | 0.1 | $6.0M | 30k | 198.03 |
|
|
| Illumina (ILMN) | 0.1 | $6.0M | -3% | 44k | 137.32 |
|
| Glaukos (GKOS) | 0.1 | $5.3M | NEW | 56k | 94.29 |
|
| Abbvie (ABBV) | 0.1 | $5.0M | +310% | 28k | 182.10 |
|
| McKesson Corporation (MCK) | 0.1 | $4.8M | +85% | 9.0k | 536.85 |
|
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.1 | $4.2M | +143% | 425k | 9.97 |
|
| Teladoc (TDOC) | 0.1 | $4.1M | +5% | 273k | 15.10 |
|
| Beigene Sponsored Adr (BGNE) | 0.1 | $3.9M | -12% | 25k | 156.39 |
|
| Doximity Cl A (DOCS) | 0.1 | $3.9M | -45% | 144k | 26.91 |
|
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 0.1 | $3.5M | +156% | 6.7k | 523.07 |
|
| Dr Reddys Labs Adr (RDY) | 0.0 | $3.0M | -32% | 41k | 73.35 |
|
| Gilead Sciences (GILD) | 0.0 | $2.4M | -35% | 33k | 73.25 |
|
| Molecular Templates Com New (MTEM) | 0.0 | $2.3M | 1.0M | 2.24 |
|
|
| Iqvia Holdings (IQV) | 0.0 | $2.1M | 8.3k | 252.89 |
|
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.0 | $2.0M | NEW | 142k | 14.11 |
|
| Nevro (NVRO) | 0.0 | $2.0M | -31% | 135k | 14.44 |
|
| CVS Caremark Corporation (CVS) | 0.0 | $1.8M | -29% | 22k | 79.76 |
|
| Certara Ord (CERT) | 0.0 | $1.7M | +5% | 96k | 17.88 |
|
| Astrazeneca Sponsored Adr (AZN) | 0.0 | $1.6M | -55% | 23k | 67.75 |
|
| Biogen Idec (BIIB) | 0.0 | $1.3M | -29% | 6.0k | 215.63 |
|
| Bristol Myers Squibb (BMY) | 0.0 | $1.3M | NEW | 23k | 54.23 |
|
| Zoetis Cl A (ZTS) | 0.0 | $1.3M | +29% | 7.5k | 169.21 |
|
| Outset Med (OM) | 0.0 | $1.3M | -67% | 572k | 2.22 |
|
| Encompass Health Corp (EHC) | 0.0 | $1.2M | +25% | 15k | 82.58 |
|
| Cytokinetics Com New (CYTK) | 0.0 | $1.1M | -17% | 16k | 70.11 |
|
| Vaneck Etf Trust Gold Miners Etf (GDX) | 0.0 | $1.0M | 33k | 31.62 |
|
|
| Johnson & Johnson (JNJ) | 0.0 | $1.0M | -77% | 6.4k | 158.19 |
|
| Pfizer (PFE) | 0.0 | $939k | +47% | 34k | 27.75 |
|
| Alphabet Cap Stk Cl C (GOOG) | 0.0 | $914k | 6.0k | 152.26 |
|
|
| Vaxcyte (PCVX) | 0.0 | $905k | -16% | 13k | 68.31 |
|
| Krystal Biotech (KRYS) | 0.0 | $856k | -39% | 4.8k | 177.93 |
|
| Alkermes SHS (ALKS) | 0.0 | $654k | -53% | 24k | 27.07 |
|
| Xenon Pharmaceuticals (XENE) | 0.0 | $607k | -35% | 14k | 43.05 |
|
| Protagonist Therapeutics (PTGX) | 0.0 | $554k | -36% | 19k | 28.93 |
|
| Rhythm Pharmaceuticals (RYTM) | 0.0 | $542k | -61% | 13k | 43.33 |
|
| Rocket Pharmaceuticals (RCKT) | 0.0 | $531k | -6% | 20k | 26.94 |
|
| 4d Molecular Therapeutics In (FDMT) | 0.0 | $500k | NEW | 16k | 31.86 |
|
| Blueprint Medicines (BPMC) | 0.0 | $484k | NEW | 5.1k | 94.86 |
|
| C4 Therapeutics Com Stk (CCCC) | 0.0 | $471k | -7% | 58k | 8.17 |
|
| Tenet Healthcare Corp Com New (THC) | 0.0 | $446k | +193% | 4.2k | 105.11 |
|
| Viking Therapeutics (VKTX) | 0.0 | $443k | -69% | 5.4k | 82.00 |
|
| Merus N V (MRUS) | 0.0 | $441k | -56% | 9.8k | 45.03 |
|
| Astrana Health Com New (ASTH) | 0.0 | $431k | NEW | 10k | 41.99 |
|
| Garmin SHS (GRMN) | 0.0 | $417k | NEW | 2.8k | 148.87 |
|
| Bridgebio Pharma (BBIO) | 0.0 | $396k | -61% | 13k | 30.92 |
|
| Verve Therapeutics (VERV) | 0.0 | $388k | -25% | 29k | 13.28 |
|
| Apple (AAPL) | 0.0 | $377k | NEW | 2.2k | 171.48 |
|
| West Pharmaceutical Services (WST) | 0.0 | $344k | NEW | 870.00 | 395.71 |
|
| Dynavax Technologies Corp Com New (DVAX) | 0.0 | $342k | -36% | 28k | 12.41 |
|
| Cardinal Health (CAH) | 0.0 | $336k | -14% | 3.0k | 111.90 |
|
| Miragen Therapeutics (VRDN) | 0.0 | $334k | -36% | 19k | 17.51 |
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.0 | $311k | -37% | 13k | 24.90 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.0 | $283k | NEW | 1.1k | 267.04 |
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.0 | $275k | +78% | 45k | 6.06 |
|
| Adma Biologics (ADMA) | 0.0 | $270k | NEW | 41k | 6.60 |
|
| Simply Good Foods (SMPL) | 0.0 | $269k | NEW | 7.9k | 34.03 |
|
| Biomea Fusion (BMEA) | 0.0 | $266k | -28% | 18k | 14.95 |
|
| Regenxbio Inc equity us cm (RGNX) | 0.0 | $253k | NEW | 12k | 21.07 |
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.0 | $221k | NEW | 4.4k | 50.23 |
|
| Baidu Spon Adr Rep A (BIDU) | 0.0 | $211k | NEW | 2.0k | 105.28 |
|
| Autolus Therapeutics Spon Ads (AUTL) | 0.0 | $207k | -35% | 33k | 6.38 |
|
| Baxter International (BAX) | 0.0 | $180k | NEW | 4.2k | 42.74 |
|
| Viatris (VTRS) | 0.0 | $173k | -19% | 15k | 11.94 |
|
| 89bio (ETNB) | 0.0 | $160k | -32% | 14k | 11.64 |
|
| Ideaya Biosciences (IDYA) | 0.0 | $145k | NEW | 3.3k | 43.88 |
|
| Mineralys Therapeutics (MLYS) | 0.0 | $119k | NEW | 9.2k | 12.91 |
|
| NVIDIA Corporation (NVDA) | 0.0 | $88k | -2% | 97.00 | 903.56 |
|
| Qualcomm (QCOM) | 0.0 | $88k | +48% | 517.00 | 169.30 |
|
| Oracle Corporation (ORCL) | 0.0 | $85k | +49% | 677.00 | 125.61 |
|
| Agilent Technologies Inc C ommon (A) | 0.0 | $79k | +48% | 540.00 | 145.51 |
|
| Microsoft Corporation (MSFT) | 0.0 | $76k | +47% | 180.00 | 420.72 |
|
| Omniab (OABI) | 0.0 | $62k | NEW | 12k | 5.42 |
|
| Mettler-Toledo International (MTD) | 0.0 | $44k | +32% | 33.00 | 1331.30 |
|
| Laboratory Corp Amer Hldgs Com New (LH) | 0.0 | $32k | -97% | 148.00 | 218.46 |
|
| Exscientia Ads (EXAI) | 0.0 | $15k | +49% | 2.6k | 5.72 |
|
| Ionq Inc Pipe (IONQ) | 0.0 | $11k | +49% | 1.1k | 9.99 |
|
Past Filings by Bellevue Group
SEC 13F filings are viewable for Bellevue Group going back to 2016
- Bellevue Group 2024 Q1 filed May 15, 2024
- Bellevue Group 2023 Q4 filed Feb. 14, 2024
- Bellevue Group 2023 Q3 filed Nov. 14, 2023
- Bellevue Group 2023 Q2 filed Aug. 14, 2023
- Bellevue Group 2023 Q1 filed May 15, 2023
- Bellevue Group 2022 Q4 filed Feb. 14, 2023
- Bellevue Group 2022 Q3 filed Nov. 14, 2022
- Bellevue Group 2022 Q2 filed Aug. 11, 2022
- Bellevue Group 2022 Q1 filed May 13, 2022
- Bellevue Group 2021 Q4 filed Feb. 10, 2022
- Bellevue Group 2021 Q3 filed Nov. 12, 2021
- Bellevue Group 2021 Q2 filed Aug. 12, 2021
- Bellevue Group 2021 Q1 filed May 12, 2021
- Bellevue Group 2020 Q4 filed Feb. 16, 2021
- Bellevue Group 2020 Q3 filed Nov. 16, 2020
- Bellevue Group 2020 Q2 filed Aug. 13, 2020